IDH1 and central nervous system cancer: Second opinion for a histopathology review should be requested whenever a malignant cortical brain tumor, i.e. IDH1 wildtype glioma, is diagnosed in a young patient with early seizure onset as principle clinical symptom [30]; D) the vast majority of LEAT are benign and assigned to WHO I° with very few documented cases of malignant progression.